{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:52:02Z","timestamp":1786996322726,"version":"build-2736575974"},"reference-count":134,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000},"content-version":"vor","delay-in-days":837,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.rmed.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T08:24:19Z","timestamp":1363767859000},"page":"800-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Role of long term antibiotics in chronic respiratory diseases"],"prefix":"10.1016","volume":"107","author":[{"given":"K.","family":"Suresh Babu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kastelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Morjaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.rmed.2013.02.009_bib1","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.2174\/1381612043383403","article-title":"Cellular and molecular effects of macrolides on leukocyte function","volume":"10","author":"Labro","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1378\/chest.10-0196","article-title":"Chronic macrolide therapy in inflammatory airways diseases","volume":"138","author":"Friedlander","year":"2010","journal-title":"Chest"},{"issue":"2 Suppl.","key":"10.1016\/j.rmed.2013.02.009_bib3","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1378\/chest.125.2_suppl.70S","article-title":"Immunomodulatory activity and effectiveness of macrolides in chronic airway disease","volume":"125","author":"Rubin","year":"2004","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2013.02.009_bib4","first-page":"CD007716","article-title":"Macrolides for diffuse panbronchiolitis","author":"Yang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. A","key":"10.1016\/j.rmed.2013.02.009_bib5","first-page":"131","article-title":"Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation","volume":"51","author":"Koyama","year":"1998","journal-title":"Jpn J Antibiot"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib6","first-page":"CD002997","article-title":"Macrolides for chronic asthma","author":"Richeldi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20133","key":"10.1016\/j.rmed.2013.02.009_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejphar.2009.06.032","article-title":"Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma","volume":"616","author":"Hrvacic","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.pupt.2009.08.004","article-title":"Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells","volume":"22","author":"Morinaga","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1081-1206(10)60935-0","article-title":"Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial","volume":"97","author":"Fonseca-Aten","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib10","doi-asserted-by":"crossref","first-page":"L847","DOI":"10.1152\/ajplung.00216.2002","article-title":"Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis","volume":"285","author":"Kaneko","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.200711-1666OC","article-title":"Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease","volume":"178","author":"Hodge","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1440-1843.2012.02135.x","article-title":"Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects","volume":"17","author":"Hodge","year":"2012","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.rmed.2013.02.009_bib13","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1128\/JCM.42.12.5842-5845.2004","article-title":"Azithromycin retards Pseudomonas aeruginosa biofilm formation","volume":"42","author":"Gillis","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.50.5.1680-1688.2006","article-title":"Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach","volume":"50","author":"Nalca","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/thorax.57.3.189","article-title":"Macrolide antibiotics and cystic fibrosis","volume":"57","author":"Peckham","year":"2002","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.rmed.2013.02.009_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/thx.2007.092858","article-title":"Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation","volume":"63","author":"Terada","year":"2008","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.rmed.2013.02.009_bib17","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.2007.146134","article-title":"Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis","volume":"57","author":"Blondeau","year":"2008","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10620-009-0725-4","article-title":"Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients","volume":"54","author":"Mertens","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.rmed.2013.02.009_bib19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.rmed.2008.06.020","article-title":"Clarithromycin inhibits fibroblast migration","volume":"102","author":"Kohyama","year":"2008","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib20","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.50.5.1738-1744.2006","article-title":"Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression","volume":"50","author":"Shinkai","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.rmed.2013.02.009_bib21","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1172\/JCI46095","article-title":"Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection","volume":"121","author":"Renna","year":"2011","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.rmed.2013.02.009_bib22","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcf.2009.12.001","article-title":"Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis","volume":"9","author":"Esther","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmed.2013.02.009_bib24","series-title":"Antibiotic treatment for cystic fibrosis: report of the UK Cystic Fibrosis Trust Antibiotic Working Group","author":"Cystic Fibrosis Foundation Trust","year":"2009"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1006\/pupt.2002.0391","article-title":"A widely available method for the assessment of aerosol delivery in cystic fibrosis","volume":"15","author":"Kastelik","year":"2002","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcf.2009.04.005","article-title":"Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus","volume":"8","author":"Heijerman","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pec.2008.08.027","article-title":"Adherence to nebulised antibiotics in cystic fibrosis","volume":"75","author":"Latchford","year":"2009","journal-title":"Patient Educ Couns"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11882-009-0086-2","article-title":"Update on infection and antibiotics in asthma","volume":"10","author":"Rollins","year":"2010","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70175-2","article-title":"Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy","volume":"103","author":"Fost","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1081-1206(10)62264-8","article-title":"Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study","volume":"87","author":"Spahn","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ppul.1076","article-title":"Anti-inflammatory effects of macrolides in lung disease","volume":"31","author":"Jaffe","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0091-6749(80)90004-4","article-title":"The effect of troleandomycin on methylprednisolone elimination","volume":"66","author":"Szefler","year":"1980","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1081\/JAS-120002199","article-title":"Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma","volume":"39","author":"Ekici","year":"2002","journal-title":"J Asthma"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1378\/chest.106.2.458","article-title":"Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma","volume":"106","author":"Shimizu","year":"1994","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.iac.2004.06.010","article-title":"Role of tumor necrosis factor alpha in asthma","volume":"24","author":"Babu","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thx.2010.136523","article-title":"Sputum IL-6 concentrations in severe asthma and its relationship with FEV1","volume":"66","author":"Morjaria","year":"2011","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0021-8707(70)90124-3","article-title":"The use of macrolide antibiotic substances in the treatment of asthma","volume":"45","author":"Itkin","year":"1970","journal-title":"J Allergy"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0091-6749(74)90027-X","article-title":"Troleandromycin: effectiveness in steroid-dependent asthma and bronchitis","volume":"54","author":"Spector","year":"1974","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib39","first-page":"37","article-title":"Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children","volume":"65","author":"Ball","year":"1990","journal-title":"Ann Allergy"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1081-1206(10)62409-X","article-title":"Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma","volume":"84","author":"Amayasu","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.164.4.2011040","article-title":"Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae","volume":"164","author":"Black","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib42","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0091-6749(93)90345-G","article-title":"Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma","volume":"91","author":"Kamada","year":"1993","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib43","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.04.00118404","article-title":"Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma","volume":"23","author":"Kostadima","year":"2004","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib44","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","article-title":"Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin","volume":"121","author":"Kraft","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm\/147.2.398","article-title":"A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids","volume":"147","author":"Nelson","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"7","key":"10.1016\/j.rmed.2013.02.009_bib46","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2222.1999.00551.x","article-title":"Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma","volume":"29","author":"Shoji","year":"1999","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib48","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/ajrccm\/147.4.832","article-title":"Measuring quality of life in asthma","volume":"147","author":"Juniper","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2500\/aap.2007.28.2958","article-title":"Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: a preliminary report","volume":"28","author":"Piacentini","year":"2007","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib50","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1371\/journal.pctr.0010011","article-title":"Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma","volume":"1","author":"Hahn","year":"2006","journal-title":"PLoS Clin Trial"},{"issue":"10","key":"10.1016\/j.rmed.2013.02.009_bib51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/thx.2005.049940","article-title":"UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation","volume":"61","author":"Price","year":"2006","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.rmed.2013.02.009_bib52","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Cataluna","year":"2005","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S681","article-title":"Role of macrolide therapy in chronic obstructive pulmonary disease","volume":"3","author":"Martinez","year":"2008","journal-title":"Int J Chronic Obstructive Pulm Dis"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib54","first-page":"379","article-title":"Prospective, comparative study (1994\u20131998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD","volume":"13","author":"Gomez","year":"2000","journal-title":"Revista espanola de quimioterapia: publicacion oficial de la Sociedad Espanola de Quimioterapia"},{"issue":"8","key":"10.1016\/j.rmed.2013.02.009_bib55","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rmed.2004.06.009","article-title":"The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD","volume":"99","author":"Banerjee","year":"2005","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1590\/S0034-71671998000300004","article-title":"Nursing assistance by a home care team after the death of the patient","volume":"51","author":"Marcon","year":"1998","journal-title":"Rev Bras Enferm"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000321374","article-title":"Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease","volume":"80","author":"He","year":"2010","journal-title":"Respiration"},{"issue":"11","key":"10.1016\/j.rmed.2013.02.009_bib59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2013.02.009_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respir Res"},{"issue":"19","key":"10.1016\/j.rmed.2013.02.009_bib61","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N Engl J Med"},{"issue":"9678","key":"10.1016\/j.rmed.2013.02.009_bib62","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"issue":"4922","key":"10.1016\/j.rmed.2013.02.009_bib63","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.rmed.2013.02.009_bib64","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1056\/NEJMe1010123","article-title":"Targeting the basic defect in cystic fibrosis","volume":"363","author":"Welsh","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.rmed.2013.02.009_bib65","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","article-title":"Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials","volume":"10","author":"Bilton","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S0950268807008278","article-title":"Ten years of viral and non-bacterial serology in adults with cystic fibrosis","volume":"136","author":"Clifton","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1183\/09031936.03.00057003","article-title":"New concepts of the pathogenesis of cystic fibrosis lung disease","volume":"23","author":"Boucher","year":"2004","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib68","first-page":"CD001912","article-title":"Prophylactic antibiotics for cystic fibrosis","author":"Smyth","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"9100","key":"10.1016\/j.rmed.2013.02.009_bib69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","article-title":"Long-term azithromycin may improve lung function in children with cystic fibrosis","volume":"351","author":"Jaffe","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":"Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"issue":"13","key":"10.1016\/j.rmed.2013.02.009_bib71","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib72","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ppul.20620","article-title":"Clinical response to azithromycin in cystic fibrosis correlates with in\u00a0vitro effects on Pseudomonas aeruginosa phenotypes","volume":"42","author":"Nguyen","year":"2007","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"10.1016\/j.rmed.2013.02.009_bib73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.2005.057950","article-title":"Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial","volume":"61","author":"Clement","year":"2006","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib74","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","author":"Southern","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib75","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1183\/09031936.00163306","article-title":"Daily versus weekly azithromycin in cystic fibrosis patients","volume":"30","author":"McCormack","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1569-1993(03)00021-3","article-title":"Improved lung function and body mass index associated with long-term use of macrolide antibiotics","volume":"2","author":"Pirzada","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcf.2004.09.001","article-title":"Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study","volume":"4","author":"Hansen","year":"2005","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib78","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2009.09.001","article-title":"Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial","volume":"9","author":"Kabra","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib79","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1183\/09031936.05.00129304","article-title":"Azithromycin in cystic fibrosis","volume":"25","author":"Kastelik","year":"2005","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O","article-title":"Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis","volume":"23","author":"Frederiksen","year":"1997","journal-title":"Pediatr Pulmonol"},{"issue":"8769","key":"10.1016\/j.rmed.2013.02.009_bib82","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0140-6736(91)91446-2","article-title":"Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment","volume":"338","author":"Valerius","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib83","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1183\/09031936.02.00248102","article-title":"A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis","volume":"20","author":"Hodson","year":"2002","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"issue":"8433","key":"10.1016\/j.rmed.2013.02.009_bib85","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(85)92222-6","article-title":"Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis","volume":"1","author":"Littlewood","year":"1985","journal-title":"Lancet"},{"issue":"5 Pt 1","key":"10.1016\/j.rmed.2013.02.009_bib86","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1164\/ajrccm.160.5.9810080","article-title":"Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study","volume":"160","author":"Crowther Labiris","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.rmed.2013.02.009_bib87","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ppul.20429","article-title":"Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis","volume":"41","author":"Gibson","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib88","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/08942680252908575","article-title":"A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia","volume":"15","author":"Ledson","year":"2002","journal-title":"J Aerosol Med"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib89","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1164\/rccm.200208-855OC","article-title":"Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis","volume":"167","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib90","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","article-title":"Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis","volume":"179","author":"Burns","year":"1999","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib91","first-page":"CD001021","article-title":"Inhaled antibiotics for long-term therapy in cystic fibrosis","author":"Ryan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmed.2013.02.009_bib92","first-page":"123","article-title":"Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis","volume":"3","author":"Daddario","year":"2010","journal-title":"Infect Drug Resist"},{"issue":"9","key":"10.1016\/j.rmed.2013.02.009_bib93","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.200712-1804OC","article-title":"Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis","volume":"178","author":"McCoy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib94","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","article-title":"Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis","volume":"135","author":"Retsch-Bogart","year":"2009","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2013.02.009_bib95","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/ppul.21301","article-title":"An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis","volume":"45","author":"Oermann","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"10.1016\/j.rmed.2013.02.009_bib96","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1164\/rccm.201008-1293OC","article-title":"Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa","volume":"183","author":"Geller","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 55","key":"10.1016\/j.rmed.2013.02.009_bib97","first-page":"333S","volume":"38","author":"Bilton","year":"2011","journal-title":"Eur Respir J"},{"issue":"Suppl. 1","key":"10.1016\/j.rmed.2013.02.009_bib98","first-page":"i1","article-title":"BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease","volume":"63","year":"2008","journal-title":"Thorax"},{"issue":"5039","key":"10.1016\/j.rmed.2013.02.009_bib99","first-page":"255","article-title":"PROLONGED antibiotic treatment of severe bronchiectasis; a report by a subcommittee of the Antibiotics Clinical Trials (non-tuberculous) Committee of the Medical Research Council","volume":"2","year":"1957","journal-title":"Br Med J"},{"issue":"280","key":"10.1016\/j.rmed.2013.02.009_bib100","first-page":"799","article-title":"Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis","volume":"76","author":"Currie","year":"1990","journal-title":"Q J Med"},{"issue":"9842","key":"10.1016\/j.rmed.2013.02.009_bib101","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib102","first-page":"540","article-title":"Prophylactic antibiotic treatment of bronchiectasis with azithromycin","volume":"59","author":"Davies","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1345\/aph.1E099","article-title":"Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa","volume":"39","author":"Drobnic","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib104","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.rmed.2013.02.009_bib105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0954-6111(99)90090-2","article-title":"Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa","volume":"93","author":"Orriols","year":"1999","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yalcin","year":"2006","journal-title":"J Clin Pharm Ther"},{"issue":"2 Pt 1","key":"10.1016\/j.rmed.2013.02.009_bib107","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. 1","key":"10.1016\/j.rmed.2013.02.009_bib108","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.83.1.63","article-title":"Diffuse panbronchiolitis. A disease of the transitional zone of the lung","volume":"83","author":"Homma","year":"1983","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.rmed.2013.02.009_bib110","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1097\/00029330-200711020-00021","article-title":"Diffuse panbronchiolitis in China: analysis of 45 cases","volume":"120","author":"Ding","year":"2007","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib111","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1378\/chest.100.3.596","article-title":"Diffuse panbronchiolitis","volume":"100","author":"Izumi","year":"1991","journal-title":"Chest"},{"issue":"6 Pt 1","key":"10.1016\/j.rmed.2013.02.009_bib112","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib113","first-page":"632","article-title":"Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis","volume":"25","author":"Kudoh","year":"1987","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"8","key":"10.1016\/j.rmed.2013.02.009_bib114","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/AAC.39.8.1688","article-title":"Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections","volume":"39","author":"Tamaoki","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.rmed.2013.02.009_bib115","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","article-title":"Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis","volume":"97","author":"Kadota","year":"2003","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib116","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.99.13613809","article-title":"Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection","volume":"13","author":"Nakamura","year":"1999","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib117","doi-asserted-by":"crossref","first-page":"711","DOI":"10.11150\/kansenshogakuzasshi1970.69.711","article-title":"Study on azithromycin in treatment of diffuse panbronchiolitis","volume":"69","author":"Kobayashi","year":"1995","journal-title":"Kansenshogaku Zasshi"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib118","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiology.189.2.8210390","article-title":"Diffuse panbronchiolitis: follow-up CT examination","volume":"189","author":"Akira","year":"1993","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib119","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1378\/chest.114.5.1411","article-title":"Bronchiolitis obliterans after lung transplantation: a review","volume":"114","author":"Boehler","year":"1998","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2013.02.009_bib120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bmt.1702642","article-title":"Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin","volume":"26","author":"Ishii","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib121","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0022-5223(05)80003-0","article-title":"Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management","volume":"110","author":"Bando","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib122","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.200212-1424BC","article-title":"Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study","volume":"168","author":"Gerhardt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.rmed.2013.02.009_bib123","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000122412.80864.43","article-title":"Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation","volume":"77","author":"Verleden","year":"2004","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.rmed.2013.02.009_bib124","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200601-071OC","article-title":"Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome","volume":"174","author":"Verleden","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.rmed.2013.02.009_bib125","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.healun.2004.08.006","article-title":"Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients","volume":"24","author":"Shitrit","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.rmed.2013.02.009_bib126","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200411-1537OC","article-title":"Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome","volume":"172","author":"Yates","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.rmed.2013.02.009_bib127","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1164\/ajrccm.173.4.465","article-title":"Azithromycin in bronchiolitis obliterans: is the evidence strong enough?","volume":"173","author":"Angel","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.rmed.2013.02.009_bib128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","article-title":"Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation","volume":"85","author":"Gottlieb","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.TP.0000149839.87843.64","article-title":"Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation","volume":"79","author":"Kotsimbos","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.healun.2003.09.042","article-title":"Chlamydia pneumoniae infection after lung transplantation","volume":"24","author":"Glanville","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.rmed.2013.02.009_bib131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.idc.2004.04.010","article-title":"Macrolides and ketolides: azithromycin, clarithromycin, telithromycin","volume":"18","author":"Zuckerman","year":"2004","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.rmed.2013.02.009_bib132","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.ftd.0000195617.69721.a5","article-title":"Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis","volume":"28","author":"Wilms","year":"2006","journal-title":"Ther Drug Monit"},{"issue":"Suppl. B","key":"10.1016\/j.rmed.2013.02.009_bib133","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/41.suppl_2.47","article-title":"Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin","volume":"41","author":"Scaglione","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.rmed.2013.02.009_bib134","first-page":"1305","article-title":"Long-term therapeutic effects of erythromycin and newquinolone antibacterial agents on diffuse panbronchiolitis","volume":"28","author":"Yamamoto","year":"1990","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611113000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611113000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:24:47Z","timestamp":1760613887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611113000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":134,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0954611113000589"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2013.02.009","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of long term antibiotics in chronic respiratory diseases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2013.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}